Provides the 2015 ESC Guidelines outlining the diagnostic and therapeutic steps for the management of patients with NSTE-ACS.
Directs NSTE-ACS care per 2015 ESC standards; leaves open need for updates with post-2015 evidence.
This section summarises the diagnostic and therapeutic steps discussed in the previous sections. The goal is to outline the most important steps in the management of patients with NSTE-ACS. In each individual patient, decision making should take into account the patient's history (e.g. age, comorbidities), clinical presentation (e.g. ongoing myocardial ischaemia, haemodynamic or electrical instability), findings obtained during the initial assessment (i.e. ECG, cardiac troponin), timing and expected risk-benefit ratio of available therapies (i.e. pharmacological, invasive assessment, revascularization).
No takes yet. Share an insight, caveat, or question.
Roffi et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: